339 related articles for article (PubMed ID: 36560648)
1. Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients.
Affeldt P; Koehler FC; Brensing KA; Gies M; Platen E; Adam V; Butt L; Grundmann F; Heger E; Hinrichs S; Kalisch N; Oehm S; Steger G; Wirtz M; Benzing T; Stippel D; Klein F; Kurschat C; Müller RU; Di Cristanziano V
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560648
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.
Benning L; Morath C; Bartenschlager M; Kim H; Reineke M; Beimler J; Buylaert M; Nusshag C; Kälble F; Reichel P; Töllner M; Schaier M; Klein K; Benes V; Rausch T; Rieger S; Stich M; Tönshoff B; Weidner N; Schnitzler P; Zeier M; Süsal C; Hien Tran T; Bartenschlager R; Speer C
Am J Transplant; 2022 Jul; 22(7):1873-1883. PubMed ID: 35384272
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.
Kawashiro K; Suzuki R; Nogimori T; Tsujino S; Iwahara N; Hirose T; Okada K; Yamamoto T; Fukuhara T; Hotta K; Shinohara N
Sci Rep; 2024 May; 14(1):12176. PubMed ID: 38806644
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.
De Bouver C; Bouziotis J; Wijtvliet VPWM; Ariën KK; Mariën J; Heyndrickx L; Couttenye MM; de Fijter HJW; Mestrez F; Treille S; Mat O; Collart F; Allard SD; Vingerhoets L; Moons P; Abramowicz D; De Winter BY; Pipeleers L; Wissing KM; Ledeganck KJ
Virol J; 2024 Jun; 21(1):138. PubMed ID: 38872127
[TBL] [Abstract][Full Text] [Related]
5. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
[TBL] [Abstract][Full Text] [Related]
6. Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation.
Iwabuchi R; Harada M; Yamada A; Aomura D; Yamada Y; Sonoda K; Nakazawa H; Sakai K; Mizukami E; Hashimoto K; Kamijo Y
Clin Exp Nephrol; 2023 Aug; 27(8):660-671. PubMed ID: 37095343
[TBL] [Abstract][Full Text] [Related]
7. Immunity against Delta and Omicron variants elicited by homologous inactivated vaccine booster in kidney transplant recipients.
Zhang L; Yang J; Lai C; Wan L; Xiong S; Kong W; Liu Z; Yu P; Chen M; Mai W; Khan SA; Deng M; Chen L; Lei Y; Zhou Q; Yu N; Li P; Chen Z; Ji T
Front Immunol; 2022; 13():1042784. PubMed ID: 36700230
[TBL] [Abstract][Full Text] [Related]
8. Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.
Charmetant X; Espi M; Benotmane I; Barateau V; Heibel F; Buron F; Gautier-Vargas G; Delafosse M; Perrin P; Koenig A; Cognard N; Levi C; Gallais F; Manière L; Rossolillo P; Soulier E; Pierre F; Ovize A; Morelon E; Defrance T; Fafi-Kremer S; Caillard S; Thaunat O
Sci Transl Med; 2022 Mar; 14(636):eabl6141. PubMed ID: 35103481
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune response and live-virus neutralization of the SARS-CoV-2 omicron (BA.1) variant after COVID-19 mRNA vaccination in children and young adults with chronic kidney disease.
Stich M; Di Cristanziano V; Tönshoff B; Weber LT; Dötsch J; Rammer MT; Rieger S; Heger E; Garbade SF; Burgmaier K; Benning L; Speer C; Habbig S; Haumann S
Pediatr Nephrol; 2023 Jun; 38(6):1935-1948. PubMed ID: 36409368
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients.
Benning L; Klein K; Morath C; Bartenschlager M; Kim H; Buylaert M; Reineke M; Töllner M; Nusshag C; Kälble F; Reichel P; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Schaier M; Speer C
Front Immunol; 2022; 13():840136. PubMed ID: 35309320
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients.
De Cagna MR; Colucci V; Di Maggio A; Notaristefano N; Cianciotta F; Danza K; Salvatore F; Santoniccolo A; Lanzillotta SG; Perniola MA; Marangi AL; Morrone LFP; Tampoia M
Clin Exp Nephrol; 2023 May; 27(5):445-453. PubMed ID: 36795176
[TBL] [Abstract][Full Text] [Related]
12. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
[TBL] [Abstract][Full Text] [Related]
13. Optimizing COVID-19 Vaccination Strategy in Pediatric Kidney Transplant Recipients: Humoral and Cellular Response to SARS-CoV-2 mRNA Vaccination.
Nel I; Parmentier C; Dehoux L; Minier M; Duneton C; Charbit M; Baudouin V; Bidet P; Carol A; Cheyssac E; Delbet JD; Guérin-El Khourouj V; Louillet F; Ulinski T; Delaugerre C; Carcelain G; Hogan J
Transpl Int; 2023; 36():11153. PubMed ID: 37252612
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Rescigno M; Agrati C; Salvarani C; Giannarelli D; Costantini M; Mantovani A; Massafra R; Zinzani PL; Morrone A; Notari S; Matusali G; Pinter GL; Uccelli A; Ciliberto G; Baldanti F; Locatelli F; Silvestris N; Sinno V; Turola E; Lupo-Stanghellini MT; Apolone G;
Front Immunol; 2023; 14():1104124. PubMed ID: 36776853
[TBL] [Abstract][Full Text] [Related]
15. Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in hemodialysis patients.
Benning L; Bartenschlager M; Kim H; Kälble F; Nusshag C; Buylaert M; Reichel P; Schaier M; Morath C; Zeier M; Schnitzler P; Bartenschlager R; Speer C
J Med Virol; 2023 Dec; 95(12):e29303. PubMed ID: 38082556
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of SARS-CoV-2 Variants of Concern in Kidney Transplant Recipients after Standard COVID-19 Vaccination.
Benning L; Morath C; Bartenschlager M; Nusshag C; Kälble F; Buylaert M; Schaier M; Beimler J; Klein K; Grenz J; Reichel P; Hidmark A; Ponath G; Töllner M; Reineke M; Rieger S; Tönshoff B; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Speer C
Clin J Am Soc Nephrol; 2022 Jan; 17(1):98-106. PubMed ID: 34937771
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Kemlin D; Gemander N; Depickère S; Olislagers V; Georges D; Waegemans A; Pannus P; Lemy A; Goossens ME; Desombere I; Michiels J; Vandevenne M; Heyndrickx L; Ariën KK; Matagne A; Ackerman ME; Le Moine A; Marchant A
Am J Transplant; 2023 May; 23(5):649-658. PubMed ID: 36773936
[TBL] [Abstract][Full Text] [Related]
18. Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.
Kühn T; Speer C; Morath C; Bartenschlager M; Kim H; Beimler J; Buylaert M; Nusshag C; Kälble F; Reineke M; Töllner M; Klein K; Blank A; Parthé S; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Tran TH; Schaier M; Benning L
Transplantation; 2023 May; 107(5):1139-1150. PubMed ID: 36617671
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Variants Omicron BA.4/5 and XBB.1.5 Significantly Escape T Cell Recognition in Solid-organ Transplant Recipients Vaccinated Against the Ancestral Strain.
Halvorson T; Ivison S; Huang Q; Ladua G; Yotis DM; Mannar D; Subramaniam S; Ferreira VH; Kumar D; Belga S; Levings MK;
Transplantation; 2024 Apr; 108(4):e49-e62. PubMed ID: 38012843
[TBL] [Abstract][Full Text] [Related]
20. Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
Ahmed-Belkacem A; Redjoul R; Brillet R; Ahnou N; Leclerc M; López-Molina DS; Soulier A; Gourgeon A; Rodriguez C; Maury S; Pawlotsky JM; Fourati S
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
